Synageva BioPharma (GEVA)

Add to Watchlists Create an Alert
73.02 +1.08  +1.50% NASDAQ Jul 30, 3:15PM BATS Real time Currency in USD

Synageva BioPharma Current Ratio (Quarterly):

34.07 for March 31, 2014

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Current Ratio (Quarterly) Chart

Export Data
Save Image

Synageva BioPharma Historical Current Ratio (Quarterly) Data

View and export this data going back to 1997. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 34.07
Dec. 31, 2013 29.94
Sept. 30, 2013 32.78
June 30, 2013 23.53
March 31, 2013 30.03
Dec. 31, 2012 17.21
Sept. 30, 2012 17.29
June 30, 2012 8.346
March 31, 2012 8.986
Dec. 31, 2011 7.828
Sept. 30, 2011 43.60
June 30, 2011 38.76
March 31, 2011 54.89
Dec. 31, 2010 10.12
Sept. 30, 2010 39.42
June 30, 2010 30.32
March 31, 2010 12.60
Dec. 31, 2009 8.513
Sept. 30, 2009 24.34
June 30, 2009 20.16
March 31, 2009 8.935
Dec. 31, 2008 9.061
Sept. 30, 2008 9.704
June 30, 2008 7.385
March 31, 2008 15.10
   
Dec. 31, 2007 12.55
Sept. 30, 2007 10.81
June 30, 2007 10.57
March 31, 2007 8.999
Dec. 31, 2006 7.015
Sept. 30, 2006 6.333
June 30, 2006 5.885
March 31, 2006 6.090
Dec. 31, 2005 6.042
Sept. 30, 2005 5.778
June 30, 2005 7.508
March 31, 2005 8.348
Dec. 31, 2004 8.183
Sept. 30, 2004 5.438
June 30, 2004 4.005
March 31, 2004 6.166
Dec. 31, 2003 5.080
Sept. 30, 2003 5.460
June 30, 2003 8.104
March 31, 2003 6.360
Dec. 31, 2002 6.856
Sept. 30, 2002 3.202
June 30, 2002 3.169
March 31, 2002 4.890
Dec. 31, 2001 3.195

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Current Ratio

The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More

Get data for
Advertisement

GEVA Current Ratio (Quarterly) Benchmarks

Companies
Agios Pharmaceuticals 5.059
Acorda Therapeutics 3.837
Egalet 29.19

GEVA Current Ratio (Quarterly) Range, Past 5 Years

Minimum 7.828 Dec 2011
Maximum 54.89 Mar 2011
Average 24.87

GEVA Current Ratio (Quarterly) Excel Add-In Codes

  • Metric Code: current_ratio
  • Latest data point: =YCP("GEVA", "current_ratio")
  • Last 5 data points: =YCS("GEVA", "current_ratio", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.